| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | NUT | 1.44e-12 | 5 | 82 | 5 | IPR024310 | |
| Domain | NUT_N | 1.44e-12 | 5 | 82 | 5 | IPR024309 | |
| Domain | NUT | 1.44e-12 | 5 | 82 | 5 | PF12881 | |
| Domain | CABIT | 3.25e-07 | 4 | 82 | 3 | PF12736 | |
| Domain | CABIT_dom | 3.25e-07 | 4 | 82 | 3 | IPR025946 | |
| Domain | PH | ELMO2 PLEKHG3 OBSCN OSBP2 TEC PHLDA2 APBB1IP GAB2 OPHN1 ARAP1 | 3.78e-07 | 278 | 82 | 10 | SM00233 |
| Domain | PH_DOMAIN | ELMO2 PLEKHG3 OBSCN OSBP2 TEC PHLDA2 APBB1IP GAB2 OPHN1 ARAP1 | 3.91e-07 | 279 | 82 | 10 | PS50003 |
| Domain | PH_domain | ELMO2 PLEKHG3 OBSCN OSBP2 TEC PHLDA2 APBB1IP GAB2 OPHN1 ARAP1 | 4.04e-07 | 280 | 82 | 10 | IPR001849 |
| Domain | PH | 7.21e-07 | 229 | 82 | 9 | PF00169 | |
| Domain | - | ELMO2 PLEKHG3 OBSCN APBB2 OSBP2 TEC PHLDA2 APBB1IP GAB2 OPHN1 ARAP1 | 1.09e-06 | 391 | 82 | 11 | 2.30.29.30 |
| Domain | PH_dom-like | ELMO2 PLEKHG3 OBSCN APBB2 OSBP2 TEC PHLDA2 APBB1IP GAB2 OPHN1 ARAP1 | 2.50e-06 | 426 | 82 | 11 | IPR011993 |
| Domain | fn3 | 7.89e-05 | 162 | 82 | 6 | PF00041 | |
| Domain | DUF3377 | 1.14e-04 | 4 | 82 | 2 | PF11857 | |
| Domain | Pept_M10A_metallopeptidase_C | 1.14e-04 | 4 | 82 | 2 | IPR021805 | |
| Domain | FN3 | 1.63e-04 | 185 | 82 | 6 | SM00060 | |
| Domain | FN3 | 2.43e-04 | 199 | 82 | 6 | PS50853 | |
| Domain | FN3_dom | 3.16e-04 | 209 | 82 | 6 | IPR003961 | |
| Domain | Pept_M10A_Zn_BS | 1.93e-03 | 15 | 82 | 2 | IPR021158 | |
| Domain | Hemopexin_CS | 2.48e-03 | 17 | 82 | 2 | IPR018486 | |
| Domain | Pept_M10A_stromelysin-type | 2.78e-03 | 18 | 82 | 2 | IPR016293 | |
| Domain | PG_binding_1 | 3.44e-03 | 20 | 82 | 2 | PF01471 | |
| Domain | Peptidoglycan-bd-like | 3.44e-03 | 20 | 82 | 2 | IPR002477 | |
| Domain | Hemopexin-like_dom | 4.54e-03 | 23 | 82 | 2 | IPR000585 | |
| Domain | Hemopexin-like_repeat | 4.54e-03 | 23 | 82 | 2 | IPR018487 | |
| Domain | M10A_MMP | 4.54e-03 | 23 | 82 | 2 | IPR033739 | |
| Domain | Hemopexin | 4.54e-03 | 23 | 82 | 2 | PF00045 | |
| Domain | HEMOPEXIN | 4.54e-03 | 23 | 82 | 2 | PS00024 | |
| Domain | - | 4.54e-03 | 23 | 82 | 2 | 2.110.10.10 | |
| Domain | HEMOPEXIN_2 | 4.54e-03 | 23 | 82 | 2 | PS51642 | |
| Domain | HX | 4.54e-03 | 23 | 82 | 2 | SM00120 | |
| Domain | Pept_M10A | 4.54e-03 | 23 | 82 | 2 | IPR021190 | |
| Domain | Peptidase_M10 | 4.94e-03 | 24 | 82 | 2 | PF00413 | |
| Domain | MetalloPept_cat_dom | 5.44e-03 | 81 | 82 | 3 | IPR024079 | |
| Domain | - | 5.44e-03 | 81 | 82 | 3 | 3.40.390.10 | |
| Domain | IQ | 5.44e-03 | 81 | 82 | 3 | SM00015 | |
| Domain | AT_hook | 6.22e-03 | 27 | 82 | 2 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 6.22e-03 | 27 | 82 | 2 | IPR017956 | |
| Domain | ZnMc | 7.16e-03 | 29 | 82 | 2 | SM00235 | |
| Domain | Peptidase_Metallo | 7.16e-03 | 29 | 82 | 2 | IPR006026 | |
| Domain | IQ_motif_EF-hand-BS | 7.28e-03 | 90 | 82 | 3 | IPR000048 | |
| Domain | IQ | 7.97e-03 | 93 | 82 | 3 | PS50096 | |
| Domain | ZF_PHD_2 | 8.45e-03 | 95 | 82 | 3 | PS50016 | |
| Domain | SAM_DOMAIN | 8.45e-03 | 95 | 82 | 3 | PS50105 | |
| Domain | CNMP_BINDING_1 | 8.67e-03 | 32 | 82 | 2 | PS00888 | |
| Domain | CNMP_BINDING_2 | 8.67e-03 | 32 | 82 | 2 | PS00889 | |
| Domain | SNF2_N | 8.67e-03 | 32 | 82 | 2 | IPR000330 | |
| Domain | SNF2_N | 8.67e-03 | 32 | 82 | 2 | PF00176 | |
| Domain | ZF_PHD_1 | 8.69e-03 | 96 | 82 | 3 | PS01359 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 4.76e-05 | 258 | 53 | 7 | MM14572 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | B4GALNT4 KMT2B GAREM2 SPEG SCN5A HECTD4 OBSCN RAPGEF1 PDZD8 MICAL3 SRCAP CEP170B ARAP1 GAREM1 PPP1R16A | 2.75e-07 | 1105 | 94 | 15 | 35748872 |
| Pubmed | 3.84e-07 | 103 | 94 | 6 | 21706016 | ||
| Pubmed | B4GALNT4 NFIA PLEKHG3 FER1L4 OBSCN FAM83G RAPGEF1 COL14A1 MICAL3 SEMA3G CHAMP1 C1orf94 CEP170B PPP1R16A | 4.82e-06 | 1215 | 94 | 14 | 15146197 | |
| Pubmed | Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing. | NUTM1 NFIA PRR20E APBB2 PRR20A NCF2 NUTM2F CBLB C1orf94 MOBP APBB1IP | 5.36e-06 | 742 | 94 | 11 | 26871637 |
| Pubmed | 7.12e-06 | 170 | 94 | 6 | 15057823 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 15185077 | ||
| Pubmed | Genetic association analysis of GDF5 and ADAM12 for knee osteoarthritis. | 7.23e-06 | 2 | 94 | 2 | 22284607 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 7559440 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 9070935 | ||
| Pubmed | Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS. | 1.16e-05 | 108 | 94 | 5 | 19531213 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 22456610 | ||
| Pubmed | A cancer cell metalloprotease triad regulates the basement membrane transmigration program. | 2.16e-05 | 3 | 94 | 2 | 16983145 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 9119382 | ||
| Pubmed | The clinical phenotype of YWHAE-NUTM2B/E positive pediatric clear cell sarcoma of the kidney. | 2.16e-05 | 3 | 94 | 2 | 26542179 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 3.40e-05 | 135 | 94 | 5 | 28675934 | |
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 15895410 | ||
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 12697763 | ||
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 35062057 | ||
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 24003223 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | KMT2B ATN1 NFIA UTP20 MICAL3 CHD4 SRRM2 CHAMP1 TERF2 CTTNBP2NL | 4.73e-05 | 774 | 94 | 10 | 15302935 |
| Pubmed | Genome- and phenome-wide analyses of cardiac conduction identifies markers of arrhythmia risk. | 7.19e-05 | 5 | 94 | 2 | 23463857 | |
| Pubmed | 7.19e-05 | 5 | 94 | 2 | 12661033 | ||
| Pubmed | Chromosomal localization and genomic cloning of the mouse alpha-tropomyosin gene Tpm-1. | 7.19e-05 | 5 | 94 | 2 | 8406508 | |
| Pubmed | MT3-MMP Promotes Excitatory Synapse Formation by Promoting Nogo-66 Receptor Ectodomain Shedding. | 7.19e-05 | 5 | 94 | 2 | 29196321 | |
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 8.97e-05 | 86 | 94 | 4 | 28327460 | |
| Pubmed | Nerve growth factor activates persistent Rap1 signaling in endosomes. | 1.08e-04 | 6 | 94 | 2 | 11466412 | |
| Pubmed | Global mapping of Salmonella enterica-host protein-protein interactions during infection. | 1.08e-04 | 6 | 94 | 2 | 34237247 | |
| Pubmed | 1.08e-04 | 6 | 94 | 2 | 14645246 | ||
| Pubmed | Membrane-type matrix metalloproteinases: Their functions and regulations. | 1.50e-04 | 7 | 94 | 2 | 25794647 | |
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 1.67e-04 | 101 | 94 | 4 | 20551380 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CASC3 PTPRB NFIA SYNJ2 PLEKHG3 HECTD4 OBSCN APBB2 MICAL3 ZHX2 MMP16 CEP170B ARAP1 | 1.84e-04 | 1489 | 94 | 13 | 28611215 |
| Pubmed | 1.87e-04 | 104 | 94 | 4 | 9205841 | ||
| Pubmed | 2.00e-04 | 8 | 94 | 2 | 23478294 | ||
| Pubmed | 3.58e-04 | 486 | 94 | 7 | 20936779 | ||
| Pubmed | 3.91e-04 | 11 | 94 | 2 | 10949161 | ||
| Pubmed | 3.91e-04 | 11 | 94 | 2 | 9653660 | ||
| Pubmed | Membrane-type MMPs are indispensable for placental labyrinth formation and development. | 6.44e-04 | 14 | 94 | 2 | 20858856 | |
| Pubmed | Pacsin 2 is required for the maintenance of a normal cardiac function in the developing mouse heart. | 6.44e-04 | 14 | 94 | 2 | 29107716 | |
| Pubmed | 6.78e-04 | 146 | 94 | 4 | 27068509 | ||
| Pubmed | Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. | 7.82e-04 | 265 | 94 | 5 | 19240061 | |
| Pubmed | 7.95e-04 | 266 | 94 | 5 | 19380743 | ||
| Pubmed | 8.08e-04 | 153 | 94 | 4 | 25037231 | ||
| Pubmed | 8.08e-04 | 153 | 94 | 4 | 10718198 | ||
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 8.27e-04 | 154 | 94 | 4 | 16055720 | |
| Pubmed | 8.46e-04 | 16 | 94 | 2 | 25035420 | ||
| Pubmed | 8.46e-04 | 16 | 94 | 2 | 21930775 | ||
| Pubmed | 8.46e-04 | 16 | 94 | 2 | 10949577 | ||
| Pubmed | 8.46e-04 | 16 | 94 | 2 | 37701782 | ||
| Pubmed | 8.89e-04 | 157 | 94 | 4 | 30186101 | ||
| Pubmed | Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction. | 9.57e-04 | 17 | 94 | 2 | 21076409 | |
| Pubmed | 1.33e-03 | 20 | 94 | 2 | 31591574 | ||
| Pubmed | The proximal signaling network of the BCR-ABL1 oncogene shows a modular organization. | 1.40e-03 | 81 | 94 | 3 | 20697350 | |
| Pubmed | 1.44e-03 | 304 | 94 | 5 | 32235678 | ||
| Pubmed | Genome-wide association study in Chinese identifies novel loci for blood pressure and hypertension. | 1.47e-03 | 21 | 94 | 2 | 25249183 | |
| Pubmed | 1.53e-03 | 182 | 94 | 4 | 15102471 | ||
| Pubmed | Functional interactions between matrix metalloproteinases and glycosaminoglycans. | 1.61e-03 | 22 | 94 | 2 | 23421805 | |
| Pubmed | 1.61e-03 | 22 | 94 | 2 | 10419448 | ||
| Pubmed | Gene-environment interaction impacts on heart development and embryo survival. | 1.61e-03 | 22 | 94 | 2 | 30787001 | |
| Pubmed | 1.61e-03 | 22 | 94 | 2 | 27527664 | ||
| Pubmed | 1.72e-03 | 87 | 94 | 3 | 12465718 | ||
| Pubmed | 1.76e-03 | 23 | 94 | 2 | 20379146 | ||
| Pubmed | 1.92e-03 | 24 | 94 | 2 | 15734845 | ||
| Pubmed | 1.92e-03 | 24 | 94 | 2 | 20168089 | ||
| Pubmed | 1.92e-03 | 24 | 94 | 2 | 25825872 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 2.34e-03 | 861 | 94 | 8 | 36931259 | |
| Pubmed | 2.47e-03 | 503 | 94 | 6 | 16964243 | ||
| Pubmed | 2.56e-03 | 100 | 94 | 3 | 10048485 | ||
| Pubmed | 2.61e-03 | 28 | 94 | 2 | 20534741 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | MYPOP KMT2B NFIA UTP20 CHD4 SRCAP SRRM2 CHAMP1 TERF2 NDUFB10 | 2.62e-03 | 1294 | 94 | 10 | 30804502 |
| Pubmed | Interaction network of human early embryonic transcription factors. | 2.68e-03 | 351 | 94 | 5 | 38297188 | |
| Interaction | ZNF683 interactions | 4.16e-10 | 10 | 91 | 5 | int:ZNF683 | |
| Interaction | KRTAP19-5 interactions | PRR20C PRR20D MYPOP PRR20B ATN1 PRR20E PRR20A CCDC17 PPP1R16A | 6.46e-10 | 99 | 91 | 9 | int:KRTAP19-5 |
| Interaction | CELF4 interactions | 7.60e-10 | 11 | 91 | 5 | int:CELF4 | |
| Interaction | BEND2 interactions | 1.30e-09 | 12 | 91 | 5 | int:BEND2 | |
| Interaction | C3orf36 interactions | 1.54e-09 | 26 | 91 | 6 | int:C3orf36 | |
| Interaction | PTTG2 interactions | 3.26e-09 | 14 | 91 | 5 | int:PTTG2 | |
| Interaction | MBNL3 interactions | 7.05e-09 | 16 | 91 | 5 | int:MBNL3 | |
| Interaction | NCK2 interactions | PRR20C PRR20D MYPOP PRR20B ATN1 PRR20E PRR20A NUTM2F CBLB ARAP1 GAREM1 | 2.75e-08 | 262 | 91 | 11 | int:NCK2 |
| Interaction | TBX6 interactions | 2.84e-08 | 41 | 91 | 6 | int:TBX6 | |
| Interaction | SH3RF1 interactions | 3.08e-08 | 108 | 91 | 8 | int:SH3RF1 | |
| Interaction | PRR34 interactions | 3.23e-08 | 21 | 91 | 5 | int:PRR34 | |
| Interaction | TPRX1 interactions | 3.23e-08 | 21 | 91 | 5 | int:TPRX1 | |
| Interaction | GRB2 interactions | CASC3 GAREM2 ABI3BP AEBP1 SYNJ2 ELMO2 PRKAR1A RAPGEF1 TEC REPS2 NUTM2F CBLB ADAM12 C1orf94 GAB2 ARAP1 GAREM1 | 1.04e-07 | 806 | 91 | 17 | int:GRB2 |
| Interaction | ATXN1 interactions | ZSWIM8 PRR20C PRR20D PRR20B KMT2B NUTM2B NFIA SYNJ2 PRR20E OBSCN PRKAR1A PRR20A RAPGEF1 CHD4 PSME2 GAPDHS ZHX2 SRRM2 C1orf94 | 1.54e-07 | 1039 | 91 | 19 | int:ATXN1 |
| Interaction | FAM9A interactions | 2.67e-07 | 59 | 91 | 6 | int:FAM9A | |
| Interaction | ZNF385C interactions | 3.61e-07 | 33 | 91 | 5 | int:ZNF385C | |
| Interaction | RHOXF2 interactions | 4.51e-07 | 104 | 91 | 7 | int:RHOXF2 | |
| Interaction | HLX interactions | 6.53e-07 | 37 | 91 | 5 | int:HLX | |
| Interaction | ZCCHC14 interactions | 6.53e-07 | 37 | 91 | 5 | int:ZCCHC14 | |
| Interaction | FAM222B interactions | 1.25e-06 | 42 | 91 | 5 | int:FAM222B | |
| Interaction | SAMD11 interactions | 1.41e-06 | 43 | 91 | 5 | int:SAMD11 | |
| Interaction | BICRAL interactions | 1.41e-06 | 43 | 91 | 5 | int:BICRAL | |
| Interaction | PITX1 interactions | 1.74e-06 | 127 | 91 | 7 | int:PITX1 | |
| Interaction | SP4 interactions | 1.99e-06 | 46 | 91 | 5 | int:SP4 | |
| Interaction | RBPMS2 interactions | 2.05e-06 | 83 | 91 | 6 | int:RBPMS2 | |
| Interaction | KRTAP19-1 interactions | 2.22e-06 | 47 | 91 | 5 | int:KRTAP19-1 | |
| Interaction | DMRT3 interactions | 2.70e-06 | 87 | 91 | 6 | int:DMRT3 | |
| Interaction | OXER1 interactions | 3.03e-06 | 50 | 91 | 5 | int:OXER1 | |
| Interaction | PRR20B interactions | 3.29e-06 | 90 | 91 | 6 | int:PRR20B | |
| Interaction | PRR20C interactions | 3.29e-06 | 90 | 91 | 6 | int:PRR20C | |
| Interaction | PRR20D interactions | 3.29e-06 | 90 | 91 | 6 | int:PRR20D | |
| Interaction | VPS37C interactions | 3.50e-06 | 141 | 91 | 7 | int:VPS37C | |
| Interaction | BANP interactions | 4.50e-06 | 277 | 91 | 9 | int:BANP | |
| Interaction | RIPPLY1 interactions | 4.89e-06 | 55 | 91 | 5 | int:RIPPLY1 | |
| Interaction | ZBTB32 interactions | 6.37e-06 | 58 | 91 | 5 | int:ZBTB32 | |
| Interaction | PRR20E interactions | 6.44e-06 | 101 | 91 | 6 | int:PRR20E | |
| Interaction | C1orf94 interactions | 7.22e-06 | 103 | 91 | 6 | int:C1orf94 | |
| Interaction | GTF2A1 interactions | 7.63e-06 | 104 | 91 | 6 | int:GTF2A1 | |
| Interaction | VENTX interactions | 7.63e-06 | 104 | 91 | 6 | int:VENTX | |
| Interaction | VEZF1 interactions | 8.07e-06 | 105 | 91 | 6 | int:VEZF1 | |
| Interaction | CABP2 interactions | 8.19e-06 | 61 | 91 | 5 | int:CABP2 | |
| Interaction | PATZ1 interactions | 9.11e-06 | 163 | 91 | 7 | int:PATZ1 | |
| Interaction | PRR20A interactions | 1.00e-05 | 109 | 91 | 6 | int:PRR20A | |
| Interaction | C10orf55 interactions | 1.12e-05 | 65 | 91 | 5 | int:C10orf55 | |
| Interaction | NOTCH3 interactions | 1.23e-05 | 113 | 91 | 6 | int:NOTCH3 | |
| Interaction | SMAP1 interactions | 1.30e-05 | 67 | 91 | 5 | int:SMAP1 | |
| Interaction | TBX3 interactions | 1.50e-05 | 69 | 91 | 5 | int:TBX3 | |
| Interaction | THAP1 interactions | 1.65e-05 | 119 | 91 | 6 | int:THAP1 | |
| Interaction | HIVEP1 interactions | 2.15e-05 | 186 | 91 | 7 | int:HIVEP1 | |
| Interaction | ESRP1 interactions | 2.57e-05 | 77 | 91 | 5 | int:ESRP1 | |
| Interaction | PRR35 interactions | 3.70e-05 | 83 | 91 | 5 | int:PRR35 | |
| Interaction | FAM168A interactions | 4.49e-05 | 142 | 91 | 6 | int:FAM168A | |
| Interaction | POU6F2 interactions | 5.65e-05 | 148 | 91 | 6 | int:POU6F2 | |
| Interaction | RBM23 interactions | 6.72e-05 | 94 | 91 | 5 | int:RBM23 | |
| Interaction | SIAH1 interactions | 6.81e-05 | 223 | 91 | 7 | int:SIAH1 | |
| Interaction | NELL2 interactions | 9.62e-05 | 53 | 91 | 4 | int:NELL2 | |
| Interaction | TRIM35 interactions | 1.04e-04 | 103 | 91 | 5 | int:TRIM35 | |
| Interaction | GLIS2 interactions | 1.19e-04 | 106 | 91 | 5 | int:GLIS2 | |
| Interaction | PHF1 interactions | 1.30e-04 | 172 | 91 | 6 | int:PHF1 | |
| Interaction | FOXH1 interactions | 1.36e-04 | 109 | 91 | 5 | int:FOXH1 | |
| Interaction | NFYC interactions | 1.52e-04 | 177 | 91 | 6 | int:NFYC | |
| Interaction | DAZAP2 interactions | 1.98e-04 | 186 | 91 | 6 | int:DAZAP2 | |
| Interaction | POGZ interactions | 1.98e-04 | 265 | 91 | 7 | int:POGZ | |
| Interaction | BHLHE40 interactions | 2.05e-04 | 119 | 91 | 5 | int:BHLHE40 | |
| Interaction | HYPK interactions | 2.57e-04 | 125 | 91 | 5 | int:HYPK | |
| Interaction | ZC3H10 interactions | 2.93e-04 | 200 | 91 | 6 | int:ZC3H10 | |
| Interaction | TCF7L2 interactions | 3.09e-04 | 285 | 91 | 7 | int:TCF7L2 | |
| Interaction | CCNK interactions | 3.31e-04 | 132 | 91 | 5 | int:CCNK | |
| Interaction | YPEL3 interactions | 3.43e-04 | 133 | 91 | 5 | int:YPEL3 | |
| Interaction | TLX3 interactions | 3.50e-04 | 291 | 91 | 7 | int:TLX3 | |
| Interaction | ANKHD1 interactions | 4.42e-04 | 216 | 91 | 6 | int:ANKHD1 | |
| Interaction | ARID5A interactions | 5.42e-04 | 147 | 91 | 5 | int:ARID5A | |
| Interaction | ROR2 interactions | 7.80e-04 | 333 | 91 | 7 | int:ROR2 | |
| Interaction | RBFOX1 interactions | 8.03e-04 | 92 | 91 | 4 | int:RBFOX1 | |
| Interaction | NCK1 interactions | 8.37e-04 | 244 | 91 | 6 | int:NCK1 | |
| Interaction | RBPMS interactions | 8.80e-04 | 340 | 91 | 7 | int:RBPMS | |
| Interaction | DPEP3 interactions | 8.86e-04 | 10 | 91 | 2 | int:DPEP3 | |
| Cytoband | 13q21.1 | 4.10e-11 | 13 | 94 | 5 | 13q21.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q21 | 4.52e-06 | 117 | 94 | 5 | chr13q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q22 | 9.08e-04 | 208 | 94 | 4 | chr10q22 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.95e-06 | 206 | 52 | 7 | 682 | |
| GeneFamily | Fibronectin type III domain containing | 9.47e-05 | 160 | 52 | 5 | 555 | |
| GeneFamily | Endogenous ligands|Matrix metallopeptidases | 2.15e-03 | 24 | 52 | 2 | 891 | |
| ToppCell | E16.5-samps-Myeloid|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.34e-08 | 156 | 91 | 7 | c7c73cef5700b0ae75280e62c94728434c712537 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.29e-07 | 190 | 91 | 7 | f6c38d197fd9d69a4f97cb2e72cd4747984c1a86 | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.64e-07 | 197 | 91 | 7 | 48a8169a4d33c6a68d66bcd936861c75cb4b60ef | |
| ToppCell | Children_(3_yrs)-Immune|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.64e-07 | 197 | 91 | 7 | f18807124b91310fcd84238484a80ecdba684679 | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.70e-07 | 198 | 91 | 7 | ea34096bee852a7e996f097fa279381afa8f86ff | |
| ToppCell | Immune|World / Lineage, Cell type, age group and donor | 1.70e-07 | 198 | 91 | 7 | 65681b54d13c6997bd90a1c2a12314a80e964fe3 | |
| ToppCell | Adult-Immune|Adult / Lineage, Cell type, age group and donor | 1.70e-07 | 198 | 91 | 7 | 9bfd7b88aa646eaf5eddb15cf985c7ca910cb35e | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD16|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.76e-07 | 199 | 91 | 7 | ac866ae110967c5867ff4601939b79861d43df54 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD16|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.82e-07 | 200 | 91 | 7 | fc061de0db2e8b5ca47f5e2a1e861018e7f1b582 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-iNKT/MAIT-T-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.19e-07 | 139 | 91 | 6 | ecc2a6ecc27748c50885cd4f0ad8a8cd1252aee6 | |
| ToppCell | P03-Hematopoietic|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.56e-07 | 141 | 91 | 6 | 4a856521520ea73291f4730fe94c5de88c2b6f0c | |
| ToppCell | P03-Hematopoietic-Immune-immune_cell_unspecified|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.30e-07 | 149 | 91 | 6 | 43d756f81d532b5c7f2306e6af9d072d496cbc8e | |
| ToppCell | P03-Hematopoietic-Immune|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.30e-07 | 149 | 91 | 6 | 1c5a2572741c47246d455c865e8e1677c9f49598 | |
| ToppCell | E16.5-samps-Myeloid-Fetal_macrophage-Proliferative_Myeloid|E16.5-samps / Age Group, Lineage, Cell class and subclass | 7.08e-07 | 152 | 91 | 6 | e427758a6e39052616a0d8ecec0c1299e81d1d3c | |
| ToppCell | E16.5-samps-Myeloid-Fetal_macrophage|E16.5-samps / Age Group, Lineage, Cell class and subclass | 7.36e-07 | 153 | 91 | 6 | e9567966fe4426176e2f2dc0be4832c769c9903a | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.91e-07 | 161 | 91 | 6 | 5a8698790f9aba796dd2b64af419055c60bd7de8 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.07e-06 | 163 | 91 | 6 | 45a0a03d642a9751f522b2f068598ab5de4a87bd | |
| ToppCell | PND01-03-samps-Myeloid|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.18e-06 | 166 | 91 | 6 | 99dc8a186ec12d3563e81fa4618a814740332c73 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Granulocytic-Basophil|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.46e-06 | 172 | 91 | 6 | 6503e85182eb6e8a40a890e393e9ac5c5350e322 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.46e-06 | 172 | 91 | 6 | 3c0bf7200e582ee730af49dcd86446e112226aca | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-06 | 175 | 91 | 6 | e991ffa4d1d278a011592b9915cd35fe76db20cc | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.66e-06 | 176 | 91 | 6 | 8e7f38de8bf68077e2138f4d06c1f55b0fd096cc | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.66e-06 | 176 | 91 | 6 | ed575330a08a6748ea4b28433292c8cfd157d444 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.84e-06 | 179 | 91 | 6 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.84e-06 | 179 | 91 | 6 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-06 | 181 | 91 | 6 | 8657d35cd3dff6c89d0fde67d7e7e81e1d6c8884 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.22e-06 | 185 | 91 | 6 | a7ae76058b2082020cadec49d63b9f4e24d21734 | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.37e-06 | 187 | 91 | 6 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.44e-06 | 188 | 91 | 6 | c2c51c6526defe2600302901159b8abbb58d7595 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-06 | 189 | 91 | 6 | 7ccea2df93bb4b37417bbc8f6c85a61ece95211a | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-06 | 191 | 91 | 6 | 9214655dca96d766737c9f30b624d7fe7050342e | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.67e-06 | 191 | 91 | 6 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.67e-06 | 191 | 91 | 6 | 468b5149d1533f03521844d3cce8633d44eb6ed4 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-06 | 192 | 91 | 6 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-06 | 193 | 91 | 6 | 06b65110db974f4ef90d3511ff34428976a52c9c | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-06 | 193 | 91 | 6 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-06 | 193 | 91 | 6 | 59b8186d0221fba06a16157e9d148399ed801f38 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-06 | 193 | 91 | 6 | a4f91bca5eaa985982d33a528f7566ffde154d47 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-06 | 193 | 91 | 6 | dc92680b4bb9fc26430c92e03adb839c8c3b3b98 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.84e-06 | 193 | 91 | 6 | bd08555f02db8bc903caacae57e80bb91e2556ce | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-06 | 193 | 91 | 6 | 03678162648bd5b1d65a5450b60c8863edbf95c7 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.84e-06 | 193 | 91 | 6 | 374d0526a071e973c3f43b4564f78f6933bb67ed | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.84e-06 | 193 | 91 | 6 | b39d7feaac4ff8f7409cd3d15e8f3c6391367275 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-06 | 194 | 91 | 6 | 96f16bcd393a0d3f8df479b172b5360ae5a1e663 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-06 | 194 | 91 | 6 | ce32e60bcea1b8baf496ce9050832bc8c77d8434 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.92e-06 | 194 | 91 | 6 | 7b6ec45adb7ece3c8a7b78c5782413b5825effe2 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-06 | 194 | 91 | 6 | a1dc157148885cc8d3685ac81a1f4e3562aeecc9 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-06 | 194 | 91 | 6 | 20a0439fa02c5f8107612e34c7ab54120b9b8573 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-06 | 194 | 91 | 6 | bc945450b350f597c3ff910d3a14a533d90086a8 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 2.92e-06 | 194 | 91 | 6 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.01e-06 | 195 | 91 | 6 | 91a3c439f10c03c5d51d904f512b6a08040edc76 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.01e-06 | 195 | 91 | 6 | 70387a62f121f8c374dba1aca9ab65cfed6a0b10 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.01e-06 | 195 | 91 | 6 | 1d58585557bf8e9ce4d514e128d3a902b526331d | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-06 | 195 | 91 | 6 | 690d6e15d7c863fc8f2d33b1f7bf86f019f415c9 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|lung / Disease (COVID-19 only), tissue and cell type | 3.01e-06 | 195 | 91 | 6 | 148fff8c3c9ba45ec36e98dff1be57e3f8294506 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-06 | 195 | 91 | 6 | 613bea20c3d82c22a6af4c1a668af6fcf11fec0a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.01e-06 | 195 | 91 | 6 | 10ce1b6961f10372d1f65388cbf3626a5fcd6840 | |
| ToppCell | Mesenchymal_cells-Endosteal_fibro.|World / Lineage and Cell class | 3.01e-06 | 195 | 91 | 6 | d53974d1866e23c894ffd492ea11d20422919b11 | |
| ToppCell | facs-Heart-RA-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.01e-06 | 195 | 91 | 6 | 5c05e2bcea3d5d7ebe6325f7187ccf83301053d8 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid-Monocytes|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.10e-06 | 196 | 91 | 6 | 4354ee481053e7b02e8c0bb16ea4377566ef2b53 | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.19e-06 | 197 | 91 | 6 | e42910a653a1b5bd90c090e9665a84871ed2873f | |
| ToppCell | COVID-19-lung-Macrophage_VCANhi_FCN1hi|lung / Disease (COVID-19 only), tissue and cell type | 3.19e-06 | 197 | 91 | 6 | a0f8a992282a6d64890f5574c7c9741fcb38dadd | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.19e-06 | 197 | 91 | 6 | 0523aec9713ae21e6b879aa98e07fa2576610d5f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.19e-06 | 197 | 91 | 6 | c9b1f2ee7eb31a66af331c5aae29e1bbb5186f5a | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.19e-06 | 197 | 91 | 6 | 8b9a88fb671d5c2b25d291c851e2b8a478f2610c | |
| ToppCell | Fetal_29-31_weeks-Immune|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.29e-06 | 198 | 91 | 6 | 5dff131356b8c22743bd27b2b21f86ee6e4a0a0d | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD16|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.29e-06 | 198 | 91 | 6 | 0b928a829844f49f4d47e88908af192cb919011f | |
| ToppCell | mLN-(5)_Dendritic_cell-(53)_Lymphoid_DC|mLN / shred on region, Cell_type, and subtype | 3.29e-06 | 198 | 91 | 6 | da84c76afe835aeee39da04b63c03549218b5d91 | |
| ToppCell | mLN-Dendritic_cell-Lymphoid_DC|mLN / Region, Cell class and subclass | 3.29e-06 | 198 | 91 | 6 | 3965a9f1e8a51a196e5349aaca5fa5ed1cd8ee92 | |
| ToppCell | Immune-monocyte|World / Lineage, Cell type, age group and donor | 3.29e-06 | 198 | 91 | 6 | d3622da252fd580f1dc5c7478a8e23df5ec083cf | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD14|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.39e-06 | 199 | 91 | 6 | 1413156b7be5373fd02bbe39ec50ccfe165fa6d1 | |
| ToppCell | proximal-3-Hematologic|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.39e-06 | 199 | 91 | 6 | dff0ca657bfb42083000e3d0125b54480b034a93 | |
| ToppCell | proximal-Hematologic|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.39e-06 | 199 | 91 | 6 | 183e388ac837585c50fed1189496167c9e61511e | |
| ToppCell | distal-3-Hematologic|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.39e-06 | 199 | 91 | 6 | 0324eb076ffe6befab03d7a9ea389a94f0644448 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.39e-06 | 199 | 91 | 6 | 6a2943a23fdd2ec814662db7c21a0d6804a6cbbc | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.39e-06 | 199 | 91 | 6 | 379bbd9cecf466b902411c54d74bd9885285b1ba | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Monocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.48e-06 | 200 | 91 | 6 | fd72fe6565e2f4885481991492d58c323ab1ad40 | |
| ToppCell | 11.5-Distal-Immune|Distal / Age, Tissue, Lineage and Cell class | 3.48e-06 | 200 | 91 | 6 | c9ed06ae7a8f5a88578c8269d762d8739ae79c7f | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Monocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.48e-06 | 200 | 91 | 6 | 48ce43a27e78b2883e588e1a63fa5352c2deeeb7 | |
| ToppCell | P07-Hematopoietic-Immune-immune_cell_unspecified|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.17e-05 | 144 | 91 | 5 | eb057dbdb2a5a2d29b93e5ed5479a3fd1bf3fd26 | |
| ToppCell | P07-Hematopoietic-Immune|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.17e-05 | 144 | 91 | 5 | 962698c5c15bd583fccda0593b7aab5f2eb4bc9f | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.77e-05 | 157 | 91 | 5 | 904cd98ae85ed6459e0663f077ac462842bf12df | |
| ToppCell | E15.5-Hematopoietic-Immune-immune_cell_unspecified|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.77e-05 | 157 | 91 | 5 | 4263627911657e788a1d0230690ee434e8a4f9a1 | |
| ToppCell | E15.5-Hematopoietic|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.77e-05 | 157 | 91 | 5 | 6315aef4b9bf673069d43a730d4e940011509ac1 | |
| ToppCell | E15.5-Hematopoietic-Immune|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.77e-05 | 157 | 91 | 5 | de689a133863ed74d848eba0a4f392357ac28245 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.83e-05 | 158 | 91 | 5 | 121d63b8e2e37107467b170e5b2c798a7dbf6325 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.88e-05 | 159 | 91 | 5 | dd9059f98eec43adbcc0cd42bb155670f7a3a479 | |
| ToppCell | E17.5-Hematopoietic|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.88e-05 | 159 | 91 | 5 | a5648f731f1a22d1af1be2b0e1b80e29d05bae04 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Treg_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.94e-05 | 160 | 91 | 5 | c2b5fadb4bac17fafc08831f6d3f4ff96ada7e70 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.94e-05 | 160 | 91 | 5 | 741e3b3f4ec5c77752da54746451f332435226e3 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.94e-05 | 160 | 91 | 5 | 778faada072e3abfa76a9a06fd4885fb63de7902 | |
| ToppCell | E17.5-Hematopoietic-Immune-immune_cell_unspecified|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.00e-05 | 161 | 91 | 5 | 30741ca6548db2dfb5cf1faecf0d7412c91d0077 | |
| ToppCell | E17.5-Hematopoietic-Immune|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.00e-05 | 161 | 91 | 5 | e3ff08d0b9c686253556c56ee88648206751ef2b | |
| ToppCell | E18.5-samps-Myeloid-Macrophage-macrophage_-_intermediate_-_unactivated|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.06e-05 | 162 | 91 | 5 | 60d3fe1f5cec4285b8774ff078ebcc6bfaec26ed | |
| ToppCell | E18.5-samps-Myeloid|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.06e-05 | 162 | 91 | 5 | 18e4a807e25f754a69e9eaaddfde40f8de9b8512 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.06e-05 | 162 | 91 | 5 | 9d6931619f5eb847c79d00ff5ae031fef30fd55c | |
| ToppCell | E18.5-samps-Myeloid-Macrophage|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.06e-05 | 162 | 91 | 5 | 0970e4eda60e3f015335e2726e6d565fb2f43372 | |
| ToppCell | PND01-Immune|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.12e-05 | 163 | 91 | 5 | 98af13bd4257a9da325e1ffe5a254f0f58ca6c4b | |
| ToppCell | PND01-Immune-Immune_Myeloid|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.12e-05 | 163 | 91 | 5 | ca12d01615be371fe215ec673d4ec787381e0ca6 | |
| ToppCell | PND01-03-samps-Myeloid-Macrophage|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.19e-05 | 164 | 91 | 5 | 49733a9d3d95f05056b5b01916060ff20a8de3cf | |
| Computational | Genes in the cancer module 387. | 1.54e-04 | 49 | 60 | 4 | MODULE_387 | |
| Computational | Genes in the cancer module 329. | 1.80e-04 | 51 | 60 | 4 | MODULE_329 | |
| Drug | Oxymetazoline hydrochloride [2315-02-8]; Up 200; 13.4uM; HL60; HG-U133A | 1.01e-06 | 198 | 88 | 8 | 1431_UP | |
| Drug | Acacetin [480-44-4]; Up 200; 14uM; MCF7; HT_HG-U133A | 1.11e-05 | 196 | 88 | 7 | 3849_UP | |
| Drug | Aminohippuric acid [61-78-9]; Up 200; 20.6uM; HL60; HT_HG-U133A | 1.15e-05 | 197 | 88 | 7 | 3076_UP | |
| Drug | Primidone [125-33-7]; Down 200; 18.4uM; MCF7; HT_HG-U133A | 1.18e-05 | 198 | 88 | 7 | 3402_DN | |
| Drug | Chlormezanone [80-77-3]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 1.18e-05 | 198 | 88 | 7 | 3235_UP | |
| Drug | Iohexol [66108-95-0]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 1.26e-05 | 200 | 88 | 7 | 3322_UP | |
| Disease | obsolete aging, cognition | 3.33e-12 | 15 | 90 | 6 | EFO_0003925, GO_0007568 | |
| Disease | Tinnitus, wellbeing measurement | 5.06e-07 | 96 | 90 | 6 | EFO_0007869, HP_0000360 | |
| Disease | t-tau:beta-amyloid 1-42 ratio measurement | 1.82e-06 | 66 | 90 | 5 | EFO_0007708 | |
| Disease | mosaic loss of chromosome Y measurement | 4.74e-06 | 80 | 90 | 5 | EFO_0007783 | |
| Disease | rheumatoid arthritis, anti-citrullinated protein antibody seropositivity, rheumatoid factor seropositivity measurement | 1.40e-05 | 170 | 90 | 6 | EFO_0000685, EFO_0007791, EFO_0007837 | |
| Disease | Knee pain | 2.75e-05 | 3 | 90 | 2 | HP_0030839 | |
| Disease | telomere length | 4.97e-05 | 313 | 90 | 7 | EFO_0004505 | |
| Disease | tyrosine-protein kinase TEC measurement | 5.50e-05 | 4 | 90 | 2 | EFO_0020830 | |
| Disease | Endometrial Stromal Sarcoma | 9.15e-05 | 5 | 90 | 2 | C0206630 | |
| Disease | Clear cell sarcoma of kidney | 1.37e-04 | 6 | 90 | 2 | C0334488 | |
| Disease | QRS-T angle | 3.17e-04 | 106 | 90 | 4 | EFO_0020097 | |
| Disease | hip bone size | 1.05e-03 | 65 | 90 | 3 | EFO_0004844 | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 1.07e-03 | 16 | 90 | 2 | DOID:0050888 (implicated_via_orthology) | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 1.21e-03 | 17 | 90 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | cystathionine measurement | 1.52e-03 | 19 | 90 | 2 | EFO_0010474 | |
| Disease | base metabolic rate measurement | 1.69e-03 | 20 | 90 | 2 | EFO_0007777 | |
| Disease | rheumatoid arthritis | 2.93e-03 | 462 | 90 | 6 | EFO_0000685 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IPRAERGNPPPIPPK | 571 | Q9P2B4 | |
| QPKGRRDPPLLPPPV | 336 | Q96LX7 | |
| VARPPSQKVRPPPPP | 711 | Q92870 | |
| APPPPEPTPRVRKAQ | 56 | Q8IUX7 | |
| VPPARSPSPPPKVVD | 741 | P54259 | |
| SARPPPAVAKRPPVP | 616 | Q7Z5R6 | |
| ETEEPIRPRPPRPKP | 421 | P58335 | |
| PRAPSVPARPLPAKP | 826 | O43184 | |
| PPPARPDKLPELPAQ | 296 | Q6P1W5 | |
| RPSPEKVPPVLPAPL | 516 | Q9Y4F5 | |
| SPNPEPPEKPVRTPE | 466 | Q9UBW5 | |
| KRLQLLPPSRPPPEP | 21 | Q96CP6 | |
| PPEKEQPPREEPRVP | 996 | Q9C0F0 | |
| QPPREEPRVPPLKIQ | 1001 | Q9C0F0 | |
| ARPVPLPVPDTKPPT | 446 | Q12857 | |
| PGEKPTIIRPPVRPP | 731 | O60890 | |
| VRRPNPSVPSPLPKP | 101 | Q8N7Y1 | |
| PAPEPVPVVAKPRPV | 201 | D6REC4 | |
| EPPKTRVPPLRPETP | 381 | Q5HY64 | |
| DRPPPPPPHIRVNEK | 1446 | P23467 | |
| PPPPPGEEPATLRRK | 1461 | Q7RTP6 | |
| REPKEPFRPPPITPH | 156 | P43026 | |
| QPQAAEPPPRPKTPE | 221 | P19878 | |
| PAPAPPPEPERPKEV | 21 | P08590 | |
| EDTPRRPPEPKPIPG | 2431 | Q9UKN7 | |
| VVPSAPPLPVRPPKT | 581 | Q96FN5 | |
| RPPKPGPPVQPRATE | 346 | P51511 | |
| VPAPPPVDIKPRQPI | 1476 | A9Z1Z3 | |
| VPLPPARPPTRDNPK | 776 | Q13191 | |
| AFKPPVPPRPQAKVP | 586 | Q8NEN9 | |
| LPPPPVPPKSEAVRE | 511 | Q9H706 | |
| PEPPRRTPVQPNPIV | 11 | O96000 | |
| LPPPRLADVAPTPPK | 161 | Q9UMN6 | |
| AKPPRTAQPPRPPVP | 746 | Q9P1Z3 | |
| PPPPLQADRRQPKEI | 1926 | Q9Y4D8 | |
| KPQPQPVPEPERGPL | 51 | Q969R2 | |
| AQRPPAPEAPKEIPP | 351 | Q86Y26 | |
| KPFRRQPPARPESPP | 56 | P86480 | |
| SAPRKPPLQPPVDPV | 506 | Q5VST9 | |
| PQTVRLAEPPKPVPP | 4611 | Q5VST9 | |
| KPFRRQPPARPESPP | 56 | P86496 | |
| KPFRRQPPARPESPP | 56 | P86481 | |
| RQRPVPEPPAPPVHI | 526 | O15234 | |
| PKPSPPRRTPQPVTI | 676 | O15234 | |
| PRRTPQPVTIKPPPP | 681 | O15234 | |
| PPKYPTAEREEPRPP | 441 | Q96B18 | |
| NIQIPEAPPPIPKEP | 696 | Q96JJ3 | |
| KPFPAVSPEPRRPAP | 291 | Q96JM3 | |
| AVPPVSPELRKPGPP | 411 | Q96JM3 | |
| RPPTFPPTIPPAKEV | 1011 | Q05707 | |
| SRRPPEPEKAPPAAP | 456 | O95466 | |
| EISPPPPNPVVKGRR | 81 | P10644 | |
| EAPKEPLQPEPAPPR | 796 | Q9BXX0 | |
| PFAVPNPKQDPRPLP | 271 | P16930 | |
| SEREHRPPEKPPRPP | 281 | Q5T9C2 | |
| QPEPTPVREEIKPPP | 41 | O14556 | |
| VAPPPPPVEVPIRKA | 246 | Q14839 | |
| PPPPPPGADRVVKAV | 16 | P16298 | |
| PPEPREKIISAPLPP | 856 | P46019 | |
| RPPPPTAAEPPAKAV | 201 | Q01101 | |
| GDPEPLPPVPKPRTV | 496 | A6ND36 | |
| PPPRPQRPAETKVPE | 496 | Q8IVF1 | |
| PPPRPQRPAETKVPE | 496 | A6NNL0 | |
| PPPRPQRPAETKVPE | 496 | B1AL46 | |
| PRLEPRGPPAPEVVK | 311 | A1L443 | |
| PRLEPRGPPAPEVVK | 311 | Q5VZR2 | |
| PAETKAHLPPPRPPR | 351 | Q5VZR2 | |
| AHLPPPRPPRPAETK | 356 | Q5VZR2 | |
| PPPRPPKPSQAETPR | 351 | Q9UQC2 | |
| REPEAPPPPVPPKSE | 461 | Q75VX8 | |
| SKEPPPQPPLAPLER | 136 | Q5HYW3 | |
| EKNPVAPAPDPRLPP | 2041 | O75691 | |
| PKEAVREGRPPEPTP | 2586 | Q9UQ35 | |
| PRVPPVPKPRTFQPG | 1281 | O15056 | |
| ALPPAPETKKRRPPP | 156 | P42680 | |
| PRPDPEPVPPVGSKR | 761 | A1L390 | |
| PEPQVPQLRAPVPEP | 26 | Q8TAP8 | |
| KPFRRQPPARPESPP | 56 | P86479 | |
| KPFRRQPPARPESPP | 56 | P86478 | |
| RPPPPEEDNPEVVRP | 396 | Q96I34 | |
| PPPPETEKVPPTRKE | 1011 | Q14524 | |
| QPRPRPEVRPPPAKQ | 136 | Q13875 | |
| PEVRPPPAKQRPPQK | 141 | Q13875 | |
| RAPLDIPIPDPPPKD | 61 | Q9UL46 | |
| EVATAPDPPPRPKPV | 976 | Q6ZRS2 | |
| APPPRPAVEQPPPKV | 511 | Q76KP1 | |
| CPPEIPPKPVRLFPE | 211 | Q96P48 | |
| PPERPTVPRKPRTEP | 36 | Q8N8Y5 | |
| DPRKNDRPKPPRPPT | 316 | P51512 | |
| MKRGEDPPTPPPRPQ | 471 | Q8NFH8 | |
| PEPRPEPVRASKPAP | 2216 | Q15772 | |
| APPPALPPKQRQLEP | 606 | Q13905 | |
| VPRIVVQPPEEPRPP | 391 | Q8IV04 | |
| VQPPEEPRPPRRKPQ | 396 | Q8IV04 | |
| KLPACEIQAPPPRPP | 541 | Q5TEJ8 | |
| EPPTATPEPPIKPRL | 1976 | P22105 | |
| EPSEPSRPSPQPKPR | 136 | Q53GA4 | |
| PRPLPTEPAVRPKEP | 531 | A7E2V4 | |
| PEPKRPHIAQVPEPP | 416 | Q9Y6X8 | |
| NLFPPEPKPEEPPAR | 681 | Q9NS98 | |
| PRPRIPQTQPVPKVP | 541 | Q7Z7G0 | |
| QPAPGPVEKPPREPA | 301 | Q15554 | |
| RPVLPPPAPKVEITP | 321 | Q86VE0 |